REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.83%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $60,924,017.61

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$814.86

▼ -8.95 (-1.09%)

As of 12/1/2023 01:00 AM ET

Days: 30 | 90 | 365

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70
3/21/2022	Marc Tessier-Lavigne	Director	Sell	7,439	$690.00	$5,132,910.00
3/21/2022	Robert E. Landry	CFO	Sell	300	$693.00	$207,900.00
3/17/2022	Robert E. Landry	CFO	Sell	83	$686.00	$56,938.00
3/16/2022	Marc Tessier-Lavigne	Director	Sell	4,361	$675.00	$2,943,675.00
2/28/2022	George L. Sing	Director	Sell	2,000	$615.50	$1,231,000.00
2/25/2022	George L. Sing	Director	Sell	2,000	$621.00	$1,242,000.00
2/23/2022	Plew Daniel P Van	EVP	Sell	6,781	$613.99	$4,163,466.19
2/1/2022	Arthur F. Ryan	Director	Sell	100	$607.14	$60,714.00
2/1/2022	Marion Mccourt	EVP	Sell	1,000	$607.46	$607,460.00
12/13/2021	Marion Mccourt	EVP	Sell	344	$653.12	$224,673.28
12/13/2021	Robert E. Landry	CFO	Sell	116	$662.50	$76,850.00
12/10/2021	Andrew J. Murphy	EVP	Sell	7,122	$666.27	$4,745,174.94
12/10/2021	Robert E. Landry	CFO	Sell	781	$666.42	$520,474.02
12/9/2021	Marc Tessier-Lavigne	Director	Sell	3,784	$665.00	$2,516,360.00
12/1/2021	Arthur F. Ryan	Director	Sell	100	$637.53	$63,753.00
12/1/2021	Marion Mccourt	EVP	Sell	1,000	$639.13	$639,130.00
11/22/2021	George L. Sing	Director	Sell	2,000	$657.50	$1,315,000.00
11/18/2021	George L. Sing	Director	Sell	4,000	$650.00	$2,600,000.00
11/17/2021	Robert E. Landry	CFO	Sell	681	$645.08	$439,299.48
11/16/2021	Andrew J. Murphy	EVP	Sell	7,167	$647.17	$4,638,267.39
11/16/2021	George L. Sing	Director	Sell	6,000	$656.26	$3,937,560.00
10/1/2021	Arthur F. Ryan	Director	Sell	100	$569.49	$56,949.00
10/1/2021	Marion Mccourt	EVP	Sell	1,000	$576.75	$576,750.00
9/15/2021	N. Anthony Coles	Director	Sell	11,948	$658.98	$7,873,493.04	7,811
9/13/2021	Michael S. Brown	Director	Sell	9,704	$648.16	$6,289,744.64	6,328
9/10/2021	Joseph L. Goldstein	Director	Sell	2,479	$650.00	$1,611,350.00	8,370
8/30/2021	George L. Sing	Director	Sell	1,000	$672.50	$672,500.00
8/26/2021	George L. Sing	Director	Sell	150	$672.00	$100,800.00	43,358
8/23/2021	Joseph J. Larosa	EVP	Sell	3,425	$661.84	$2,266,802.00	23,182
8/18/2021	Leonard S. Schleifer	CEO	Sell	200,000	$650.03	$130,006,000.00
8/18/2021	P. Roy Vagelos	Director	Sell	10,039	$650.04	$6,525,751.56
8/13/2021	George L. Sing	Director	Sell	500	$620.00	$310,000.00	47,063
8/11/2021	George L. Sing	Director	Sell	2,000	$620.50	$1,241,000.00	47,063
8/10/2021	Daniel P. Van Plew	EVP	Sell	6,603	$611.86	$4,040,111.58	51,931
8/9/2021	Michael S. Brown	Director	Sell	1,687	$612.38	$1,033,085.06
8/9/2021	Robert E. Landry	CFO	Sell	364	$617.83	$224,890.12
8/5/2021	Bonnie L. Bassler	Director	Sell	2,559	$600.00	$1,535,400.00	3,450
8/5/2021	George D. Yancopoulos	Insider	Sell	50,000	$600.06	$30,003,000.00	937,483
8/2/2021	Marion Mccourt	EVP	Sell	1,000	$577.12	$577,120.00	18,038
7/6/2021	Joseph J. Larosa	EVP	Sell	3,398	$580.00	$1,970,840.00	23,182
7/1/2021	Arthur F. Ryan	Director	Sell	100	$564.50	$56,450.00	23,589
6/25/2021	Michael S. Brown	Director	Sell	2,084	$549.00	$1,144,116.00	2,975
6/21/2021	George D. Yancopoulos	Insider	Sell	80,000	$538.90	$43,112,000.00	987,483
6/14/2021	Arthur F. Ryan	Director	Sell	100	$524.76	$52,476.00	23,673
5/7/2021	Marion Mccourt	EVP	Sell	1,000	$495.63	$495,630.00	18,038
1/25/2021	Michael S. Brown	Director	Sell	2,480	$554.32	$1,374,713.60	3,371
12/1/2020	Arthur F. Ryan	Director	Sell	100	$520.48	$52,048.00	23,741

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

84.15% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/1/2023	B. Riley Wealth Advisors Inc.	1,006	$0.83M	0.0%	-7.6%	0.001%
12/1/2023	Wellington Management Group LLP	1,506,885	$1.24B	0.2%	-9.7%	1.383%
11/30/2023	American Century Companies Inc.	916,718	$754.42M	0.6%	+3.4%	0.841%
11/30/2023	Modera Wealth Management LLC	9,583	$7.89M	0.1%	+2.9%	0.009%
11/28/2023	ASB Consultores LLC	255	$0.21M	0.1%	-36.4%	0.000%
11/28/2023	IMA Wealth Inc.	3,287	$2.71M	0.7%	-1.3%	0.003%
11/27/2023	AllSquare Wealth Management LLC	55	$45K	0.0%	+89.7%	0.000%
11/27/2023	USA Financial Formulas	2,695	$2.22M	3.3%	-0.6%	0.002%
11/27/2023	Banque Pictet & Cie SA	617	$0.51M	0.0%	-74.2%	0.001%
11/24/2023	Deutsche Bank AG	271,631	$223.54M	0.1%	-9.4%	0.249%
11/24/2023	EP Wealth Advisors LLC	1,046	$0.86M	0.0%	-99.8%	0.001%
11/22/2023	Public Sector Pension Investment Board	11,434	$9.41M	0.1%	+10.7%	0.010%
11/21/2023	Comerica Bank	16,306	$13.42M	0.1%	-26.4%	0.015%
11/21/2023	Braun Stacey Associates Inc.	21,024	$17.30M	0.8%	+0.2%	0.019%
11/16/2023	Integrated Advisors Network LLC	274	$0.23M	0.0%	N/A	0.000%
11/16/2023	Creative Planning	6,668	$5.49M	0.0%	+9.0%	0.006%
11/16/2023	TLS Advisors LLC	250	$0.21M	0.8%	N/A	0.000%
11/16/2023	Cravens & Co Advisors LLC	1,300	$1.07M	1.0%	+5.8%	0.001%
11/16/2023	BRYN MAWR TRUST Co	635	$0.52M	0.0%	-3.9%	0.001%
11/16/2023	Harbour Investments Inc.	384	$0.32M	0.0%	-15.8%	0.000%
11/16/2023	Tudor Investment Corp Et Al	5,799	$4.77M	0.0%	-57.5%	0.005%
11/16/2023	Belpointe Asset Management LLC	812	$0.67M	0.1%	+117.7%	0.001%
11/16/2023	Public Employees Retirement System of Ohio	66,268	$54.54M	0.2%	-5.7%	0.061%
11/16/2023	Fairfield Bush & CO.	1,935	$1.59M	1.0%	+6.3%	0.002%
11/16/2023	Morgan Stanley	970,957	$799.06M	0.1%	+2.7%	0.891%
11/16/2023	Penserra Capital Management LLC	634	$0.52M	0.0%	-14.8%	0.001%
11/15/2023	Integrated Wealth Concepts LLC	457	$0.38M	0.0%	-7.3%	0.000%
11/15/2023	Wunderlich Capital Managemnt	4,220	$3.47M	1.7%	-0.8%	0.004%
11/15/2023	Townsquare Capital LLC	6,702	$5.52M	0.1%	+5.4%	0.006%
11/15/2023	Jag Capital Management LLC	262	$0.22M	0.0%	N/A	0.000%
11/15/2023	Mercer Global Advisors Inc. ADV	21,000	$17.28M	0.1%	+8.9%	0.019%
11/15/2023	Toroso Investments LLC	4,122	$3.39M	0.1%	-34.6%	0.004%
11/15/2023	iA Global Asset Management Inc.	9,863	$8.12M	0.1%	+5.1%	0.009%
11/15/2023	The Manufacturers Life Insurance Company	365,974	$301.18M	0.2%	+0.4%	0.336%
11/15/2023	Adalta Capital Management LLC	245	$0.20M	0.1%	N/A	0.000%
11/15/2023	Krensavage Asset Management LLC	47,256	$38.89M	14.3%	-20.2%	0.043%
11/15/2023	Royal Bank of Canada	159,933	$131.62M	0.0%	+4.6%	0.147%
11/15/2023	Royal London Asset Management Ltd.	40,581	$33.40M	0.1%	+4.2%	0.037%
11/15/2023	Schroder Investment Management Group	33,443	$27.52M	0.0%	-29.7%	0.031%
11/15/2023	Scotia Capital Inc.	294	$0.24M	0.0%	N/A	0.000%
11/15/2023	Sectoral Asset Management Inc.	3,720	$3.06M	0.6%	+16.4%	0.003%
11/15/2023	Sei Investments Co.	20,128	$16.56M	0.0%	-3.9%	0.018%
11/15/2023	Seven Eight Capital LP	975	$0.80M	0.1%	N/A	0.001%
11/15/2023	JT Stratford LLC	1,471	$1.21M	0.3%	+35.1%	0.001%
11/15/2023	Kelly Lawrence W & Associates Inc. CA	240	$0.20M	0.1%	-34.2%	0.000%
11/15/2023	Legal & General Group Plc	820,208	$675M	0.2%	-3.2%	0.753%
11/15/2023	Lido Advisors LLC	1,451	$1.19M	0.0%	-31.2%	0.001%
11/15/2023	EHP Funds Inc.	900	$0.74M	0.3%	-66.7%	0.001%
11/15/2023	Ellerson Group Inc. ADV	7,095	$5.84M	5.4%	-1.9%	0.007%
11/15/2023	Evergreen Capital Management LLC	5,023	$4.13M	0.2%	-29.4%	0.005%
11/15/2023	Adage Capital Partners GP L.L.C.	94,749	$77.98M	0.2%	-31.4%	0.087%
11/15/2023	AIMZ Investment Advisors LLC	10,610	$8.73M	3.9%	-0.6%	0.010%
11/15/2023	Alps Advisors Inc.	400	$0.33M	0.0%	-5.9%	0.000%
11/15/2023	Ameriprise Financial Inc.	365,674	$300.94M	0.1%	-2.9%	0.336%
11/15/2023	Armistice Capital LLC	74,998	$61.72M	0.9%	-39.5%	0.069%
11/15/2023	Augustine Asset Management Inc.	4,332	$3.57M	1.6%	-3.0%	0.004%
11/15/2023	Advisors Asset Management Inc.	9,395	$7.73M	0.2%	+4.2%	0.009%
11/15/2023	Alberta Investment Management Corp	2,400	$1.98M	0.0%	-66.9%	0.002%
11/15/2023	Shelton Capital Management	12,239	$10.07M	0.4%	+28.6%	0.011%
11/15/2023	First National Bank of Omaha	526	$0.43M	0.0%	-52.9%	0.000%
11/15/2023	Wahed Invest LLC	1,628	$1.34M	0.4%	+9.6%	0.001%
11/15/2023	Glenmede Trust Co. NA	84,758	$69.75M	0.4%	+1.5%	0.078%
11/15/2023	Truist Financial Corp	52,443	$43.16M	0.1%	-35.2%	0.048%
11/15/2023	AQR Capital Management LLC	190,169	$156.50M	0.3%	-13.4%	0.175%
11/15/2023	Insigneo Advisory Services LLC	397	$0.33M	0.1%	+11.8%	0.000%
11/14/2023	Lazard Asset Management LLC	11,056	$9.10M	0.0%	-0.9%	0.010%
11/14/2023	Waverly Advisors LLC	782	$0.64M	0.0%	-6.5%	0.001%
11/14/2023	Caisse DE Depot ET Placement DU Quebec	148,071	$121.86M	0.4%	-17.9%	0.136%
11/14/2023	Schonfeld Strategic Advisors LLC	4,035	$3.32M	0.0%	+344.4%	0.004%
11/14/2023	Rehmann Capital Advisory Group	483	$0.40M	0.0%	+4.3%	0.000%
11/14/2023	Gotham Asset Management LLC	3,247	$2.67M	0.1%	-67.0%	0.003%
11/14/2023	Corton Capital Inc.	1,348	$1.11M	0.6%	-23.3%	0.001%
11/14/2023	Karani Asset Management LLC	5,378	$4.43M	6.4%	-29.7%	0.005%
11/14/2023	Fred Alger Management LLC	62,920	$51.78M	0.3%	+74,804.8%	0.058%
11/14/2023	Ancora Advisors LLC	192	$0.16M	0.0%	-6.3%	0.000%
11/14/2023	Sherbrooke Park Advisers LLC	447	$0.37M	0.1%	N/A	0.000%
11/14/2023	Teza Capital Management LLC	495	$0.41M	0.0%	-8.0%	0.000%
11/14/2023	Avidity Partners Management LP	58,000	$47.73M	1.9%	+133.9%	0.053%
11/14/2023	Itau Unibanco Holding S.A.	242	$0.20M	0.0%	+8.0%	0.000%
11/14/2023	California State Teachers Retirement System	170,740	$140.51M	0.2%	-3.3%	0.157%
11/14/2023	Van Lanschot Kempen Investment Management N.V.	4,835	$3.98M	0.1%	+9.1%	0.004%
11/14/2023	Toronto Dominion Bank	59,716	$49.14M	0.1%	-3.4%	0.055%
11/14/2023	Bank of Nova Scotia	51,468	$42.36M	0.1%	+99.9%	0.047%
11/14/2023	Clough Capital Partners L P	575	$0.47M	0.1%	-92.6%	0.001%
11/14/2023	Tower Research Capital LLC TRC	5,161	$4.25M	0.1%	-52.9%	0.005%
11/14/2023	Synovus Financial Corp	1,657	$1.36M	0.0%	+4.0%	0.002%
11/14/2023	Tiemann Investment Advisors LLC	235	$0.19M	0.1%	-17.5%	0.000%
11/14/2023	Treasurer of the State of North Carolina	58,378	$48.04M	0.3%	-1.0%	0.054%
11/14/2023	Valley National Advisers Inc.	1,370	$1.13M	0.2%	+2.5%	0.001%
11/14/2023	Mather Group LLC.	1,059	$0.87M	0.0%	+13.6%	0.001%
11/14/2023	Meeder Advisory Services Inc.	1,223	$1.01M	0.1%	-18.4%	0.001%
11/14/2023	Morse Asset Management Inc	4,107	$3.38M	1.1%	+4.7%	0.004%
11/14/2023	Mutual Advisors LLC	2,054	$1.69M	0.1%	+153.0%	0.002%
11/14/2023	O Shaughnessy Asset Management LLC	5,737	$4.72M	0.1%	+80.2%	0.005%
11/14/2023	Oak Associates Ltd. OH	9,826	$8.09M	0.7%	+0.4%	0.009%
11/14/2023	Profund Advisors LLC	10,166	$8.37M	0.5%	+19.9%	0.009%
11/14/2023	Parkside Financial Bank & Trust	162	$0.13M	0.0%	+11.0%	0.000%
11/13/2023	Natixis Advisors L.P.	111,021	$91.37M	0.3%	-0.1%	0.102%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	2,666	$2.19M	0.0%	-84.3%	0.002%
11/13/2023	Covestor Ltd	233	$0.19M	0.1%	+25.9%	0.000%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $814.86

$808.89

$828.13

50 Day Range

MA: $812.62

$775.18

$843.66

52 Week Range

Now: $814.86

$668.00

$853.97

Volume

560,216 shs

Average Volume

562,136 shs

Market Capitalization

$88.78 billion

P/E Ratio

23.24

Dividend Yield

N/A

Beta

0.13

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Robert E Landry (CFO)
Arthur F Ryan (Director)
Marion Mccourt (EVP)
Christopher R Fenimore (SVP)
Joseph J Larosa (EVP)
Joseph L Goldstein (Director)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Huda Y Zoghbi (Director)
Michael S Brown (Director)
N Anthony Coles (Director)
Bonnie L Bassler (Director)
Andrew J Murphy (EVP)
George L Sing (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
FMR LLC — 9.03%
Wellington Management Group LLP — 1.38%
Loomis Sayles & Co. L P — 1.14%
Northern Trust Corp — 0.98%
Morgan Stanley — 0.89%
Bank of New York Mellon Corp — 0.89%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
EP Wealth Advisors LLC
Massachusetts Financial Services Co. MA
Invesco Ltd.
Wellington Management Group LLP
California Public Employees Retirement System
Armistice Capital LLC
Mitsubishi UFJ Trust & Banking Corp
Loomis Sayles & Co. L P
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Robert E Landry (CFO)
Arthur F Ryan (Director)
Marion Mccourt (EVP)
Christopher R Fenimore (SVP)
Joseph J Larosa (EVP)
Joseph L Goldstein (Director)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
FMR LLC
TD Asset Management Inc
Fred Alger Management LLC
Citigroup Inc.
Canada Pension Plan Investment Board
Northern Trust Corp
Avidity Partners Management LP
DekaBank Deutsche Girozentrale